Use of a novel cation-exchange restricted-access material for automated sample clean-up prior to the determination of basic drugs in plasma by liquid chromatography.
A new kind of silica-based restricted-access material (RAM) has been tested in pre-columns for the on-line solid-phase extraction (SPE) of basic drugs from directly injected plasma samples before their quantitative analysis by reversed-phase liquid chromatography (LC), using the column switching technique. The outer surface of the porous RAM particlescontains hydrophilic diol groups while sulphonic acid groups are bound to the internal surface, which gives the sorbent the properties of a strong cation exchanger towards low molecular mass compounds. Macromolecules such as proteins have no access to the internal surface of the pre-column due to their exclusion from the pores and are then flushed directly out. The retention capability of this novel packing material has been tested for some hydrophilic basic drugs, such as atropine, fenoterol, ipratropium, procaine, sotalol and terbutaline, used as model compounds. The influence of the composition of the washing liquid on the retention of the analytes in the pre-column has been investigated. The elution profiles of the different compounds and the plasma matrix as well as the time needed for the transfer of the analytes from the pre-column to the analytical column were determined in order to deduce the most suitable conditions for the clean-up step and develop on-line methods for the LC determination of these compounds in plasma. The cationic exchange sorbent was also compared to another RAM, namely RP-18 ADS (alkyl diol silica) sorbent with respect to retention capability towards basic analytes.
Chiap
P
P
Department of Analytical Pharmaceutical Chemistry, Institute of Pharmacy, University of Liège, CHU-B36, B-400 Liège 1, Belgium.
Rbeida
O
O
Christiaens
B
B
Hubert
Ph
P
Lubda
D
D
Boos
K S
KS
Crommen
J
J
D001331:Automation; D002411:Cation Exchange Resins; D002853:Chromatography, Liquid / Q000379:methods*; D004364:Pharmaceutical Preparations / Q000097:blood*
D002411:Cation Exchange Resins; D004364:Pharmaceutical Preparations